Reasons to invest in Novavax for the long term?

1. Innovative vaccine technology: Novavax's JN.1 COVID-19 vaccine uses recombinant protein technology, provides protection from a wide range of variants of the virus, and complies with WHO and FDA recommendations.

2. Global market expansion: Novavax plans to expand its international market share by making its latest vaccine available globally this fall.

3. Strategic cooperation: Cooperate with Sanofi to jointly promote COVID-19 vaccines and develop combined influenza and COVID-19 vaccines to enhance market position and financial prospects.

Novavax's technical advantages, market expansion, and strategic partnerships have made it a company with huge investment potential.